Migraine Research Study Application

Principal Investigator Dr. Joel Saper is conducting a clinical research study evaluating an investigational nasal spray medication for the treatment of migraine headaches. The investigational medication is a new formulation of intranasal sumatriptan. Intranasal sumatriptan is an FDA-approved medication for the treatment of acute migraine. Researchers want to learn if a new formulation will begin to work faster to relieve migraine.

To qualify for this study, individuals must:

  • be between 18 and 75 years of age
  • experience 2–8 headaches per month
  • meet other study eligibility criteria

If you qualify, you will receive study-required exams and study medication at no cost to you. During the study, you will treat two migraine headaches with either active medication or placebo. In addition, you may be compensated for your time and travel expenses.

Please complete the following profile and a Research Nurse will contact you.


Contact Information
Description of Headache
Questions/Comments For Research Nurse:

The message area below should not be used by individuals who have a clinical circumstance under question which needs direct involvement of a medical professional. Individuals who need direct involvement of a medical professional should contact him/her directly.

Providing this information is voluntary and will be kept as private as possible. Your information will not be sold or shared with other parties without your permission or except as required by law. By submitting this form we have your permission to securely and indefinitely keep your information on file or database and to contact you for possible participation in a future research study. Your information will be removed from the database at any time, just by contacting us.